Alignment Healthcare (ALHC) – Investment Analysts’ Recent Ratings Changes

Alignment Healthcare (NASDAQ: ALHC) has recently received a number of price target changes and ratings updates:

• 10/28/2026 – Alignment Healthcare is now covered by Needham & Company LLC. They set a “hold” rating on the stock.
• 10/22/2026 – Alignment Healthcare had its “buy” rating reaffirmed by The Goldman Sachs Group. They now have a $12.00 price target on the stock.
• 10/12/2026 – Alignment Healthcare had its price target lowered by UBS Group from $22.00 to $9.00. They now have a “neutral” rating on the stock.
• 10/12/2026 – Alignment Healthcare had its “outperform” rating reaffirmed by Raymond James Financial.
• 10/12/2026 – Alignment Healthcare had its price target lowered by UBS Group from $22.00 to $9.00. They now have a “hold” rating on the stock.
• 10/12/2026 – Alignment Healthcare had its price target lowered by TD Cowen from $21.00 to $12.00. They now have a “buy” rating on the stock.
• 10/9/2026 – Alignment Healthcare was downgraded by Weiss Ratings from “hold (c)” to “hold (c-)”.
• 10/9/2026 – Alignment Healthcare was given a new $9.00 price target by Scotiabank.
• 10/9/2026 – Alignment Healthcare was downgraded by William Blair from “outperform” to “market perform”.
• 10/9/2026 – Alignment Healthcare had its price target lowered by JPMorgan Chase & Co. from $22.00 to $10.00. They now have an “overweight” rating on the stock.
• 10/9/2026 – Alignment Healthcare had its price target lowered by KeyCorp from $28.00 to $12.00. They now have an “overweight” rating on the stock.
• 10/6/2026 – Alignment Healthcare had its price target lowered by Barclays from $16.00 to $10.00. They now have an “equal weight” rating on the stock.
• 9/25/2026 – Alignment Healthcare was upgraded by Weiss Ratings from “hold (c-)” to “hold (c)”.
• 9/16/2026 – Alignment Healthcare had its “buy” rating reaffirmed by TD Cowen.

Insiders Place Their Bets

In related news, insider Hyong Kim sold 32,479 shares of the company’s stock in a transaction on Tuesday, October 6th. The shares were sold at an average price of $8.30, for a total transaction of $269,575.70. Following the completion of the transaction, the insider owned 299,271 shares in the company, valued at approximately $2,483,949.30. This represents a 9.79% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, President Dawn Maroney sold 122,707 shares of the stock in a transaction dated Friday, September 11th. The shares were sold at an average price of $12.68, for a total transaction of $1,555,924.76. Following the transaction, the president directly owned 794,606 shares of the company’s stock, valued at $10,075,604.08. This trade represents a 13.38% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 1,061,967 shares of company stock valued at $13,642,490 in the last 90 days. 5.20% of the stock is currently owned by company insiders.

Alignment Healthcare, Inc is a technology-enabled health insurance company focused on providing Medicare Advantage plans for seniors. The company combines health plan coverage with care coordination and clinical services designed to help members manage chronic conditions, access providers and navigate the health care system.

Its offerings include Medicare Advantage plans, supplemental benefits and member support services. Alignment also uses its proprietary technology platform, including the Alignment Virtual Application (AVA), to support care teams, analyze health information and help deliver more personalized services to members.

Founded in 2013, Alignment Healthcare serves Medicare-eligible consumers in selected markets, including California, Florida, Nevada and North Carolina.